Elsevier acquires Windhover
This article was originally published in The Gray Sheet
Executive Summary
FDC Reports' parent company Elsevier builds upon its news and business intelligence services for the medical device and drug industries with the acquisition of Windhover Information, announced March 10. Windhover's businesses include the Strategic Transactions Database, a number of device and drug partnering and strategy conferences, and the journals IN VIVO and RPM Report. Windhover will operate within Elsevier's Pharma Business Intelligence Unit, which includes FDC Reports, publisher of "The Gray Sheet" and "The Pink Sheet," and the Inteleos drug development database